192 related articles for article (PubMed ID: 11037964)
1. The protective effect of IFN-gamma in experimental autoimmune diseases: a central role of mycobacterial adjuvant-induced myelopoiesis.
Matthys P; Vermeire K; Heremans H; Billiau A
J Leukoc Biol; 2000 Oct; 68(4):447-54. PubMed ID: 11037964
[TBL] [Abstract][Full Text] [Related]
2. Enhanced autoimmune arthritis in IFN-gamma receptor-deficient mice is conditioned by mycobacteria in Freund's adjuvant and by increased expansion of Mac-1+ myeloid cells.
Matthys P; Vermeire K; Mitera T; Heremans H; Huang S; Schols D; De Wolf-Peeters C; Billiau A
J Immunol; 1999 Sep; 163(6):3503-10. PubMed ID: 10477624
[TBL] [Abstract][Full Text] [Related]
3. The effects of NO synthase inhibitors on murine collagen-induced arthritis do not support a role of NO in the protective effect of IFN-gamma.
Vermeire K; Thielemans L; Matthys P; Billiau A
J Leukoc Biol; 2000 Jul; 68(1):119-24. PubMed ID: 10914498
[TBL] [Abstract][Full Text] [Related]
4. Suppression of autoimmune neuritis in IFN-gamma receptor-deficient mice.
Zhu Y; Ljunggren HG; Mix E; Li HL; van der Meide P; Elhassan AM; Winblad B; Zhu J
Exp Neurol; 2001 Jun; 169(2):472-8. PubMed ID: 11358460
[TBL] [Abstract][Full Text] [Related]
5. IFN-gamma increases the severity and accelerates the onset of experimental autoimmune uveitis in transgenic rats.
Egwuagu CE; Sztein J; Mahdi RM; Li W; Chao-Chan C; Smith JA; Charukamnoetkanok P; Chepelinsky AB
J Immunol; 1999 Jan; 162(1):510-7. PubMed ID: 9886427
[TBL] [Abstract][Full Text] [Related]
6. Endogenous systemic IFN-gamma has a protective role against ocular autoimmunity in mice.
Caspi RR; Chan CC; Grubbs BG; Silver PB; Wiggert B; Parsa CF; Bahmanyar S; Billiau A; Heremans H
J Immunol; 1994 Jan; 152(2):890-9. PubMed ID: 8283058
[TBL] [Abstract][Full Text] [Related]
7. Protective role of IFN-gamma in collagen-induced arthritis conferred by inhibition of mycobacteria-induced granulocyte chemotactic protein-2 production.
Kelchtermans H; Struyf S; De Klerck B; Mitera T; Alen M; Geboes L; Van Balen M; Dillen C; Put W; Gysemans C; Billiau A; Van Damme J; Matthys P
J Leukoc Biol; 2007 Apr; 81(4):1044-53. PubMed ID: 17200147
[TBL] [Abstract][Full Text] [Related]
8. Critical role for IFN-gamma in natural killer cell-mediated protection from diabetes.
Lee IF; Qin H; Priatel JJ; Tan R
Eur J Immunol; 2008 Jan; 38(1):82-9. PubMed ID: 18085661
[TBL] [Abstract][Full Text] [Related]
9. Collagen-induced arthritis as an animal model for rheumatoid arthritis: focus on interferon-γ.
Schurgers E; Billiau A; Matthys P
J Interferon Cytokine Res; 2011 Dec; 31(12):917-26. PubMed ID: 21905879
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous effects of IFN-gamma in adjuvant arthritis.
Jacob CO; Holoshitz J; Van der Meide P; Strober S; McDevitt HO
J Immunol; 1989 Mar; 142(5):1500-5. PubMed ID: 2493048
[TBL] [Abstract][Full Text] [Related]
11. Ameliorated course of glucose-6-phosphate isomerase (G6PI)-induced arthritis in IFN-γ receptor knockout mice exposes an arthritis-promoting role of IFN-γ.
Frey O; Mitera T; Kelchtermans H; Schurgers E; Kamradt T; Matthys P
J Autoimmun; 2011 Mar; 36(2):161-9. PubMed ID: 21262564
[TBL] [Abstract][Full Text] [Related]
12. Treatment with anti-interferon-gamma monoclonal antibodies modifies experimental autoimmune encephalomyelitis in interferon-gamma receptor knockout mice.
Espejo C; Penkowa M; Sáez-Torres I; Xaus J; Celada A; Montalban X; Martínez-Cáceres EM
Exp Neurol; 2001 Dec; 172(2):460-8. PubMed ID: 11716570
[TBL] [Abstract][Full Text] [Related]
13. Oral tolerance in the control of experimental models of autoimmune disease.
Staines NA; Harper N
Z Rheumatol; 1995; 54(3):145-54. PubMed ID: 7660685
[TBL] [Abstract][Full Text] [Related]
14. Mac-1(+) myelopoiesis induced by CFA: a clue to the paradoxical effects of IFN-gamma in autoimmune disease models.
Matthys P; Vermeire K; Billiau A
Trends Immunol; 2001 Jul; 22(7):367-71. PubMed ID: 11429320
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary inflammation in mice with collagen-induced arthritis is conditioned by complete Freund's adjuvant and regulated by endogenous IFN-γ.
Schurgers E; Mertens F; Vanoirbeek JA; Put S; Mitera T; De Langhe E; Billiau A; Hoet PH; Nemery B; Verbeken E; Matthys P
Eur J Immunol; 2012 Dec; 42(12):3223-34. PubMed ID: 22930199
[TBL] [Abstract][Full Text] [Related]
16. Modes of action of Freund's adjuvants in experimental models of autoimmune diseases.
Billiau A; Matthys P
J Leukoc Biol; 2001 Dec; 70(6):849-60. PubMed ID: 11739546
[TBL] [Abstract][Full Text] [Related]
17. Systemic juvenile idiopathic arthritis-like syndrome in mice following stimulation of the immune system with Freund's complete adjuvant: regulation by interferon-γ.
Avau A; Mitera T; Put S; Put K; Brisse E; Filtjens J; Uyttenhove C; Van Snick J; Liston A; Leclercq G; Billiau AD; Wouters CH; Matthys P
Arthritis Rheumatol; 2014 May; 66(5):1340-51. PubMed ID: 24470407
[TBL] [Abstract][Full Text] [Related]
18. Freund's complete adjuvant induces arthritis in mice lacking a functional interferon-gamma receptor by triggering tumor necrosis factor alpha-driven osteoclastogenesis.
Geboes L; De Klerck B; Van Balen M; Kelchtermans H; Mitera T; Boon L; De Wolf-Peeters C; Matthys P
Arthritis Rheum; 2007 Aug; 56(8):2595-607. PubMed ID: 17665444
[TBL] [Abstract][Full Text] [Related]
19. Complete Freund's adjuvant suppresses the development and progression of pristane-induced arthritis in rats.
Zheng CL; Hossain MA; Kukita A; Ohki K; Satoh T; Kohashi O
Clin Immunol; 2002 May; 103(2):204-9. PubMed ID: 12027426
[TBL] [Abstract][Full Text] [Related]
20. Anti-interferon-gamma antibodies in the treatment of autoimmune diseases.
Skurkovich B; Skurkovich S
Curr Opin Mol Ther; 2003 Feb; 5(1):52-7. PubMed ID: 12669471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
